Login to Your Account



Pharma: Clinic Roundup


Thursday, September 5, 2013
Endo Pharmaceuticals Inc., of Malvern, Pa., and Biodelivery Sciences International Inc., of Raleigh, N.C., completed interim analysis in a Phase III trial of BEMA Buprenorphine.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription